Clinical Trial Update: ANIMATE: Phase II Study of Nivolumab Monotherapy for Relapsed/Refractory Hodgkin Lymphoma [Phase 2]

View source ↗

Summary

This is a Phase II clinical trial evaluating nivolumab monotherapy for relapsed or refractory Hodgkin lymphoma, sponsored by University College London; the stud…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hodgkin Lymphoma

Drugs mentioned

• nivolumab (nivolumab)

Snippet

Sponsor: University College, London | Conditions: Hodgkin Lymphoma | Phase 2 | Status: ACTIVE_NOT_RECRUITING